Islamic countries set out plans for self-reliance in vaccine production

9 August 2010

Islamic countries have acknowledged the importance of self-reliance in vaccine production and are committed to establishing closer cooperation towards achieving this end, as they ended their 6th Annual Meeting of Self-Reliance in Vaccine Production (SRVP), in Bandung, Indonesia.

SRVP is supported by Islamic Development Bank (IDB), and the three-day meeting which ended yesterday has elected Indonesia`s state-owned PT Bio Farma as the new focal point for Projects Implementation Monitoring and the Razi Institute of Iran as the Training Manager.

In view of the increasing constraints caused by ever more stringent requirements from the World Health Organization, SRVP members agreed to constitute a task force from within their membership to formulate their proposals for input in the new WHO draft prequalification guidelines. Indonesia will assist vaccine producers in Organization of Islamic Conference (OIC) countries ' which number 57 - to accelerate their achievement of WHO prequalification.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical